Evolent Health, Inc. (EVH)

Market Cap	283.56M -75.6%
Revenue (ttm)	1.88B -26.6%
Net Income	-579.40M
EPS	-5.07
Shares Out	111.64M
PE Ratio	n/a
Forward PE	14.80
Dividend	n/a
Ex-Dividend Date	n/a

Volume	3,084,198
Open	2.350
Previous Close	2.310
Day's Range	2.350 - 2.640
52-Week Range	2.095 - 12.065
Beta	0.37
Analysts	Strong Buy
Price Target	7.93 (+212.21%)
Earnings Date	May 7, 2026

About EVH

Evolent Health, Inc., through its subsidiary, provides specialty care management services in oncology, cardiology, and musculoskeletal markets in the United States. The company offers integrated value-based care platform for health plan administration and management. It also provides administrative services, such as health plan services, pharmacy benefits management, risk management, analytics and reporting, and leadership and management; and Identifi, a proprietary technology system that aggregates and analyzes data, manages care workflows, an...

• Industry: Health Information Services
• Sector: Healthcare
• IPO Date: Jun 5, 2015
• Employees: 4,200
• Stock Exchange: NYSE
• Ticker Symbol: EVH
• Website: https://www.evolent.com

Financial Performance

In 2025, Evolent Health's revenue was $1.88 billion, a decrease of -26.56% compared to the previous year's $2.55 billion. Losses were -$579.40 million, 520.0% more than in 2024.

Analyst Summary

According to 15 analysts, the average rating for EVH stock is "Strong Buy." The 12-month stock price target is $7.93, which is an increase of 212.21% from the latest price.

Price Target

$7.93

(212.21% upside)

Analyst Consensus: Strong Buy